Browse diseases

…Objectives The management of SLE varies worldwide. Current SLE treatment goals focus on controlling disease activity and preve…

…rythematosus (SLE), mixed connective tissue disease (MCTD), and antiphospholipid syndrome (APS) followed at two tertiary care centers in Denmark during 2…

…nd neuropsychiatric manifestations are two troublesome areas in systemic lupus erythematosus (SLE). The type I interferon (IFN) system plays a pivotal role …

…ainst NPSLE. Additional action is required in the management of SLE patients with high disease activity and self-reported cognitive…

…posure and the need for rescue therapies. Early optimisation of SLE management and effective disease control may also lead to great…

…ing belimumab versus placebo, plus standard therapy. Real-world SLE remission data for patients in the USA initiating belimumab are…

…Objectives Anti-dsDNA IgG antibodies are characteristic for systemic lupus erythematosus (SLE). Evidence suggests that these antibodies contribute to va…

…Background Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease with mul…

…Objectives Systemic lupus erythematosus (SLE) is a complex autoimmune disease. Significant morbidity an…

…gh not statistically significant.Conclusions Thai patients with SLE demonstrated an immune response comparable to that of healthy c…

…ed cells.Results Patients with SLE had significantly higher BPA SLE score than controls in the discovery (OR 1.34, p=4.6×10-13), re…

…n Low VDR concentration is a common phenomenon in patients with SLE associated with age, high disease activity, vitamin D supply an…